Submitted by David Avitabile on Mon, 05/13/2013 - 10:59
Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi
BioNJ, the trade association for New Jersey’s biotechnology industry, is hosting its biggest and most interactive event of the year for companies involved in diagnostics and personalized medicine on June 6, 2013 at Sanofi’s US headquarters in Bridgewater, NJ.
Expanded this year due to the success of last year’s inaugural event, the 2013 BioNJ Diagnostics & Personalized Medicine Innovation Summit will bring together leaders from major global biotechnology and pharmaceutical companies, diagnostics companies and emerging “innovator” companies for a full-day, interactive summit meeting.
J&J releases more Doxil to the market
Fierce Pharma
Drug maker JNJ: $327M deceptive marketing penalty should be invalidated because no one in SC hurt
Yahoo/AP
Janssen submits NDA to FDA for canagliflozin/metformin
Yahoo/Fly on the Wall
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Mylan Launches Generic Version of Sporanox® Capsules By Mylan Inc.
Sacramento Bee, CA
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
- Abbott Laboratories
- AC Immune
- Angiochem
- AstraZeneca
- BioDelivery Sciences
- Biogen Idec
- Bionomics
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- Enanta
- Endo
- Endocyte
- Forma Therapeutics
- Galapagos
- Genentech
- Genmab
- GSK
- Inhibrx Thrombogenics
- Ironwood
- Isis Pharmaceuticals
- Janssen
- LEO Pharma
- licensing
- MannKind
- Merck
- Merck KGaA
- Novartis
- Threshold Pharmaceuticals
- Tolero Pharmaceuticals
- Virobay
- Xenon
Pipeline Progress at Alkermes/JNJ
Yahoo/Zacks

